200 related articles for article (PubMed ID: 35073841)
21. ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer.
He F; Xiao H; Cai Y; Zhang N
Cell Commun Signal; 2021 May; 19(1):53. PubMed ID: 33980247
[TBL] [Abstract][Full Text] [Related]
22. LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p.
Zhang C; Lian H; Xie L; Yin N; Cui Y
Biol Chem; 2020 Aug; 401(9):1053-1061. PubMed ID: 32229685
[TBL] [Abstract][Full Text] [Related]
23. Rhein suppresses esophageal cancer development by regulating cell cycle through DNMT3B gene.
Li C; Yu J; Feng Y; Sun X; Sun M; Ni W; Shao J; Wang B
Med Oncol; 2024 May; 41(6):153. PubMed ID: 38743323
[TBL] [Abstract][Full Text] [Related]
24. Identification of hub necroptosis-related lncRNAs for prognosis prediction of esophageal carcinoma.
Luo Z; Ding E; Yu L; Wang W; Guo Q; Li X; Wang Y; Li T; Zhang Y; Zhang X
Aging (Albany NY); 2023 Jun; 15(11):4794-4819. PubMed ID: 37263709
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the Roles of Suppressor of Cytokine Signaling-3 in Esophageal Carcinoma.
Yang X; Tian M; Lin Y; Li L; Sun X; Zhang Z; Kang M; Lin J
Hum Gene Ther; 2023 Jun; 34(11-12):495-517. PubMed ID: 36932739
[TBL] [Abstract][Full Text] [Related]
26. Identification of Autophagy-Related Genes and Small-Molecule Drugs in Esophageal Carcinoma.
Li Z; Dong K; Guo P; Tan Z; Zhang F; Tian Y; Lv H
Med Sci Monit; 2020 May; 26():e921855. PubMed ID: 32415055
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
28. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z
Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409
[TBL] [Abstract][Full Text] [Related]
29. Expression of the CLCA4 Gene in Esophageal Carcinoma and Its Impact on the Biologic Function of Esophageal Carcinoma Cells.
Song X; Zhang S; Li S; Wang Y; Zhang X; Xue F
J Oncol; 2021; 2021():1649344. PubMed ID: 34194494
[TBL] [Abstract][Full Text] [Related]
30. USP53 activated by H3K27 acetylation regulates cell viability, apoptosis and metabolism in esophageal carcinoma via the AMPK signaling pathway.
Cheng W; Tang Y; Tong X; Zhou Q; Xie J; Wang J; Han Y; Ta N; Ye Z
Carcinogenesis; 2022 May; 43(4):349-359. PubMed ID: 34919659
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
Yang S; Li X; Shen W; Hu H; Li C; Han G
J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
[TBL] [Abstract][Full Text] [Related]
32. LncRNA miR205HG hinders HNRNPA0 translation: anti-oncogenic effects in esophageal carcinoma.
Dong X; Chen X; Lu D; Diao D; Liu X; Mai S; Feng S; Xiong G
Mol Oncol; 2022 Feb; 16(3):795-812. PubMed ID: 34821009
[TBL] [Abstract][Full Text] [Related]
33. Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activation.
Togayachi A; Kozono Y; Ishida H; Abe S; Suzuki N; Tsunoda Y; Hagiwara K; Kuno A; Ohkura T; Sato N; Sato T; Hirabayashi J; Ikehara Y; Tachibana K; Narimatsu H
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15829-34. PubMed ID: 17890318
[TBL] [Abstract][Full Text] [Related]
34. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
Yu-Jing T; Wen-Jing T; Biao T
Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
[TBL] [Abstract][Full Text] [Related]
35. N-linked polylactosamine glycan synthesis is regulated by co-expression of β3GnT2 and GCNT2.
Henion TR; Schwarting GA
J Cell Physiol; 2014 Apr; 229(4):471-8. PubMed ID: 24105809
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of CDK5 as a novel biomarker for progression in esophageal cancer.
Ling R; Sheng Y; Hu Y; Wang D; Zhou Y; Shu Y
Esophagus; 2023 Jul; 20(3):502-514. PubMed ID: 36853485
[TBL] [Abstract][Full Text] [Related]
37. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
[TBL] [Abstract][Full Text] [Related]
38. Development of Multiscale Transcriptional Regulatory Network in Esophageal Cancer Based on Integrated Analysis.
Xu Z; Wu Z; Zhang J; Zhou R; Wu J; Yu B
Biomed Res Int; 2020; 2020():5603958. PubMed ID: 32851080
[TBL] [Abstract][Full Text] [Related]
39. Pan-cancer analysis identifies ESM1 as a novel oncogene for esophageal cancer.
Cui Y; Guo W; Li Y; Shi J; Ma S; Guan F
Esophagus; 2021 Apr; 18(2):326-338. PubMed ID: 33175267
[TBL] [Abstract][Full Text] [Related]
40. THAP9-AS1/miR-133b/SOX4 positive feedback loop facilitates the progression of esophageal squamous cell carcinoma.
Cheng J; Ma H; Yan M; Xing W
Cell Death Dis; 2021 Apr; 12(4):401. PubMed ID: 33854048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
